REGENXBIO Inc. - Common Stock (RGNX)

CUSIP: 75901B107

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock
Shares outstanding
50,868,756
Total 13F shares
37,122,782
Share change
+137,118
Total reported value
$742,048,193
Put/Call ratio
43%
Price per share
$19.99
Number of holders
165
Value change
+$3,963,188
Number of buys
77
Number of sells
78

Quarterly Holders Quick Answers

What is CUSIP 75901B107?
CUSIP 75901B107 identifies RGNX - REGENXBIO Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RGNX - REGENXBIO Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
16%
8,040,790
$152,051,338 31 Mar 2023
13F
VANGUARD GROUP INC
13F
Company
8.5%
4,317,021
$81,634,867 31 Mar 2023
13F
JPMORGAN CHASE & CO
13F
Company
7.9%
4,005,623
$75,746,000 31 Mar 2023
13F
STATE STREET CORP
13F
Company
5.1%
2,581,263
$48,811,683 31 Mar 2023
13F
Redmile Group, LLC
13F
Company
3.2%
1,640,725
$31,026,110 31 Mar 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
3%
1,536,131
$29,046,462 31 Mar 2023
13F
Aquilo Capital Management, LLC
13F
Company
1.6%
831,014
$15,714,475 31 Mar 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.5%
760,797
$14,386,677 31 Mar 2023
13F
CITADEL ADVISORS LLC
13F
Company
1.5%
743,357
$14,056,881 31 Mar 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.4%
719,211
$13,600,000 31 Mar 2023
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
1.2%
632,378
$11,958,268 31 Mar 2023
13F
MPM BioImpact LLC
13F
Company
1.2%
617,671
$11,680,159 31 Mar 2023
13F
Invesco Ltd.
13F
Company
1.2%
602,837
$11,399,648 31 Mar 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.1%
556,711
$10,527,405 31 Mar 2023
13F
FIRST MANHATTAN CO. LLC.
13F
Company
0.88%
447,730
$8,466,574 31 Mar 2023
13F
NORTHERN TRUST CORP
13F
Company
0.81%
410,398
$7,760,626 31 Mar 2023
13F
WS MANAGEMENT LLLP
13F
Company
0.78%
396,997
$7,507,213 31 Mar 2023
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.75%
380,751
$7,200,001 31 Mar 2023
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.74%
376,300
$7,115,833 31 Mar 2023
13F
Bank of New York Mellon Corp
13F
Company
0.7%
354,883
$6,710,837 31 Mar 2023
13F
MORGAN STANLEY
13F
Company
0.65%
328,565
$6,213,163 31 Mar 2023
13F
Woodline Partners LP
13F
Company
0.6%
305,822
$5,783,094 31 Mar 2023
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.58%
293,508
$5,550,236 31 Mar 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.57%
289,607
$5,476,469 31 Mar 2023
13F
MIRABELLA FINANCIAL SERVICES LLP
13F
Company
0.05%
25,983
$5,461,344 31 Mar 2023
13F
NORGES BANK
13F
Company
0.53%
270,942
$5,123,513 31 Mar 2023
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.48%
242,026
$4,576,712 31 Mar 2023
13F
ArchPoint Investors
13F
Company
0.44%
224,278
$4,241,097 31 Mar 2023
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.39%
198,630
$3,756,093 31 Mar 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.39%
198,250
$3,748,907 31 Mar 2023
13F
Sonic GP LLC
13F
Company
0.38%
193,079
$3,651,124 31 Mar 2023
13F
ROYCE & ASSOCIATES LP
13F
Company
0.36%
182,450
$3,450,130 31 Mar 2023
13F
Mirae Asset Global Investments Co., Ltd.
13F
Company
0.34%
170,714
$3,228,202 31 Mar 2023
13F
MACQUARIE GROUP LTD
13F
Company
0.29%
149,000
$2,818,000 31 Mar 2023
13F
Lombard Odier Asset Management (Switzerland) SA
13F
Company
0.26%
130,369
$2,465,278 31 Mar 2023
13F
Rafferty Asset Management, LLC
13F
Company
0.25%
129,015
$2,439,674 31 Mar 2023
13F
CITIGROUP INC
13F
Company
0.24%
123,867
$2,342,325 31 Mar 2023
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.23%
117,987
$2,231,134 31 Mar 2023
13F
Legal & General Group Plc
13F
Company
0.22%
111,997
$2,117,865 31 Mar 2023
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.22%
110,720
$2,093,715 31 Mar 2023
13F
ExodusPoint Capital Management, LP
13F
Company
0.21%
106,943
$2,022,000 31 Mar 2023
13F
Nuveen Asset Management, LLC
13F
Company
0.2%
103,541
$1,958,000 31 Mar 2023
13F
RHUMBLINE ADVISERS
13F
Company
0.2%
103,146
$1,950,000 31 Mar 2023
13F
Hennion & Walsh Asset Management, Inc.
13F
Company
0.2%
102,263
$1,934,000 31 Mar 2023
13F
FIRST TRUST ADVISORS LP
13F
Company
0.17%
84,305
$1,594,207 31 Mar 2023
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.16%
83,302
$1,575,241 31 Mar 2023
13F
Swiss National Bank
13F
Company
0.16%
79,400
$1,501,454 31 Mar 2023
13F
JUPITER ASSET MANAGEMENT LTD
13F
Company
0.15%
74,046
$1,399,469 31 Mar 2023
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.14%
71,412
$1,350,401 31 Mar 2023
13F
UBS Group AG
13F
Company
0.14%
69,581
$1,315,777 31 Mar 2023
13F

Institutional Holders of REGENXBIO Inc. - Common Stock (RGNX) as of Q2 2023

As of 30 Jun 2023, REGENXBIO Inc. - Common Stock (RGNX) was held by 165 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,122,782 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, STATE STREET CORP, Redmile Group, LLC, DIMENSIONAL FUND ADVISORS LP, Aquilo Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, WS MANAGEMENT LLLP, and Sonic GP LLC. This page lists 165 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
170
Q2 2023 holders
165
Holder diff
-5
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .